bioecon Member area
Technology · Marine blue bioeconomy / Marine biotech

Marine Fish-Skin Collagen Peptides and Fish Gelatin Bioprocessing

Advanced biomanufacturing and industrial formulation of marine fish-skin collagen peptides and fish gelatin bioprocessing. Cold water washing of tilapia, cod, or salmon skins and scales with food-grade citric acid or dilute hydrochloric acid for calcium demineralization..

1 · What it gives

Marine Fish-Skin Collagen Peptides and Fish Gelatin Bioprocessing defines the forefront of biofabrication and regenerative medicine, constructing patient-specific, three-dimensional, living tissue constructs or implantable biomaterials capable of anatomical restoration and physiological integration. By integrating computer-aided design (CAD/CAM), stimuli-responsive or biofunctional polymer inks, and live-cell extrusion or light-based stereolithography (SLA/DLP), the platform bridges the gap between synthetic biomaterials and native extracellular matrix (ECM). The technology addresses foundational bottlenecks of microvascular perfusability, mechanical mismatch, and cellular ischemia in thick tissue constructs.

The industrial manufacturing train unites medical-grade biomaterial synthesis (such as recombinant humanized collagen, PCL, PLGA, or gelatin-methacryloyl GelMA), multi-axis pneumatic or digital light processing bioprinters, and dynamic perfusion biomimetic bioreactors. In-line stereomicroscopy and optical coherence tomography (OCT) ensure sub-20 um spatial resolution across multi-layered constructs. Fabricated tissue grafts undergo dynamic mechanical conditioning (pulsatile flow, cyclical stretch) to accelerate ECM deposition, maturation, and functional endothelialization before preclinical or clinical transplantation.

The key directions of this technology are:

  1. Biomimetic Bioink Chemistry & Rheology in Marine Fish-Skin Collagen Peptides and Fish Gelatin Bioprocessing: Engineering shear-thinning hydrogels with rapid post-extrusion photo-crosslinking (e.g., LAP photoinitiator with 405 nm visible light) to maintain high shape fidelity and >90% cell viability.
  2. Sacrificial Pluronic / Gelatin Microvascular Channeling: Utilizing thermally reversible sacrificial fugitive inks to pattern interconnected hierarchical vascular networks within centimeter-scale tissue volumes.
  3. Biomimetic Perfusion Conditioning Bioreactors: Applying physiological pulsatile shear stress and cyclic strain to stimulate smooth muscle and endothelial cell alignment, accelerating vascular graft maturation.
  4. Biomaterial Biodegradation & Mechanical Mechanics Control: Tailoring polymer molecular weights and crosslinking densities to synchronize scaffold degradation kinetics with native ECM neo-synthesis in vivo.

Sectoral value chain#

┌────────────────────────────────────────────────────────┐
│  Tier 1: Medical-Grade Biomaterial & Bioink Synthesis  │
│  (rhCollagen, GelMA, LAP photoinitiator, cell seeding) │
└───────────────────────────────────┬────────────────────┘
                                    │
                                    ▼
┌────────────────────────────────────────────────────────┐
│  Tier 2: Patient Anatomical CAD Modeling & Slicing     │
│  (CT/MRI 3D reconstruction, G-code toolpath routing)   │
└───────────────────────────────────┬────────────────────┘
                                    │
                                    ▼
┌────────────────────────────────────────────────────────┐
│  Tier 3: Multi-Material Bioprinting & Crosslinking     │
│  (Pneumatic extrusion/DLP, visible light photocuring)  │
└───────────────────────────────────┬────────────────────┘
                                    │
                                    ▼
┌────────────────────────────────────────────────────────┐
│  Tier 4: Dynamic Perfusion Maturation Bioreactor       │
│  (Pulsatile flow, mechanical stretch, endothelization) │
└───────────────────────────────────┬────────────────────┘
                                    │
                                    ▼
┌────────────────────────────────────────────────────────┐
│  Tier 5: Mechanical, Histological & Sterile Release QC │
│  (Tensile burst pressure, suture retention, ISO 10993) │
└────────────────────────────────────────────────────────┘

Value chain levels#

LevelDescriptionKey inputs/outputs
Biomaterial Precursor SynthesisPrecision synthesis and endotoxin purification of clinical-grade bioinks and synthetic polymers.In: Raw gelatin/PCL, methacrylic anhydride, LAP, WFI.
Out: Endotoxin-tested, sterile-filtered bioink components (<0.5 EU/mL).
Anatomical Modeling & Toolpath SlicingTranslating patient DICOM volumetric scans into multi-layered toolpaths optimized for printability.In: Patient CT/MRI imaging data, CAD/CAM slicing software.
Out: Validated numerical G-code routines for multi-nozzle bioprinting.
Robotic Bioprinting & PhotopolymerizationDeposition of living cell-laden inks and structural polymers followed by controlled 405 nm photo-curing.In: Cell-laden bioink, sacrificial ink, multi-head bioprinter.
Out: Structurally coherent, vascularized multi-tissue constructs.
Perfusion Bioreactor Tissue MaturationCulturing constructs under dynamic pulsatile flow and physiological strain to promote native ECM remodeling.In: Printed constructs, specialized bioreactor chambers, media.
Out: Matured living tissue graft with continuous patent lumens.
Biomechanical & Biological Release TestingComprehensive validation of tensile modulus, suture retention strength, cell viability, and sterility.In: Mature graft specimens, mechanical testing fixtures.
Out: Fully released, clinical-transplantation grade tissue implant.

Cross-cutting technologies of the sector:

  • Optical Coherence Tomography (OCT) Metrology: Real-time non-destructive volumetric scanning verifying internal lumen patency and wall thickness.
  • Biaxial Mechanical & Burst Pressure Testing: Ensuring engineered vascular conduits and soft tissues withstand arterial hemodynamic pressures (>1500 mmHg).

2 · What it replaces 6 · matched by industry

D1E–Fermentation cosmetic ingredients instead of shark-liver squalene, rooster-comb hyaluronic acid and animal collagen
Replaces: Shark-liver oil squalene (deep-sea shark fisheries); hyaluronic acid from rooster combs; bovine/porcine collagen extracts (and their …
COSM
D3E–Citric acid by Aspergillus niger fermentation instead of extraction from citrus fruit
Replaces: Citric acid extracted from lemons, limes and other citrus (calcium citrate route, Italy and California before 1930)
FOOD
D3E2Glutamate and MSG by bacterial fermentation instead of protein hydrolysis and chemical synthesis
Replaces: Hydrolysis of wheat gluten or soybean protein with hydrochloric acid (1909–1960s); acrylonitrile-based chemical synthesis (Japan, …
FOOD
D3E–Enzymatic high-fructose syrup from starch instead of sucrose and acid hydrolysis
Replaces: Cane and beet sucrose in beverages and processed foods; acid hydrolysis of starch for glucose syrup
FOOD
D1E2Microalgal omega-3 oils (DHA/EPA) instead of fish oil and krill oil
Replaces: Wild-capture fish oil and Antarctic krill oil for omega-3 (food, supplements, infant formula) and part of the aquafeed fish-oil fraction; …
FOOD
D1E–Baking enzymes (fungal amylase, maltogenic amylase, xylanase, glucose oxidase, lipase) plus ascorbic acid instead of potassium bromate and azodicarbonamide as flour treatment agents
Replaces: Potassium bromate (KBrO₃) and azodicarbonamide (ADA) used as oxidizing flour improvers/dough conditioners; part of chemical emulsifier use …
FOOD

3 · How to implement 4 steps

  1. 1
    Raw Fish Skin Washing & Demineralization
  2. 2
    Thermal Gelatin Extraction or Multienzyme HydrolysisExtractionSynthesis & conversion
  3. 3
    Ceramic Membrane Nanofiltration & DeodorizationPurification & downstream
  4. 4
    Centrifugal Spray Drying & Heavy Metal ClearancePurification & downstreamRegulatory & certification

4 · Who delivers

Matched suppliers (matched automatically)

Biopolytech Co., Ltd.South KoreaProduceractive
HaesinSouth KoreaResearch / RTOactive
Jiangsu TrautecChinaProduceractive
Mukka Proteins LimitedIndiaProduceractive

Leading companies and institutes (from the brief)

Company / InstituteCountryKey products / platformsTech featuresStatus 2026
Miltenyi Biotec🇩🇪 GermanyCliniMACS Prodigy Automated ProcessingStandardized cGMP ATMP bioprocess module and validated analytical release assay suite.Commercial / Approved
Lonza Cell & Gene🇨🇭 SwitzerlandCocoon Closed Manufacturing PlatformStandardized cGMP ATMP bioprocess module and validated analytical release assay suite.Commercial / Approved
Cytiva🇺🇸 United StatesXuri Cell Expansion Bioreactors & SefiaStandardized cGMP ATMP bioprocess module and validated analytical release assay suite.Commercial / Approved
WuXi Advanced Therapies🇨🇳 ChinaViral Vector Testing & Analytical DevelopmentStandardized cGMP ATMP bioprocess module and validated analytical release assay suite.Commercial / Approved
Sartorius Stedim Biotech🇩🇪 GermanyAmbr Bioreactors & Process PAT SystemsStandardized cGMP ATMP bioprocess module and validated analytical release assay suite.Commercial / Approved
Thermo Fisher Scientific🇺🇸 United StatesGibco CTS Cell Therapy MediaStandardized cGMP ATMP bioprocess module and validated analytical release assay suite.Commercial / Approved

5 · Rules & route to market

Route into Russia / EAEU: COSM · EAEU conformity bodies (Rospotrebnadzor for SGR)
declaration (SGR for some categories)
Information, not legal advice — confirm the procedure for your product. (2026-10-06)
United States

FDA CDRH/CBER combination product pathways, ARMI BioFab, ISO 10993#

  • FDA Combination Product Guidelines: Jurisdictional oversight for Marine Fish-Skin Collagen Peptides and Fish Gelatin Bioprocessing navigating drug-device or biologic-device designations between CBER and CDRH.
  • ARMI BioFabUSA Manufacturing Consortia: National manufacturing institute standardizing modular automated biofabrication cleanroom systems.
  • ISO 10993 Biocompatibility Testing: Rigorous preclinical evaluation of cytotoxicity, genotoxicity, systemic toxicity, and hemocompatibility.

European Union

EU Medical Device Regulation (MDR 2017/745), Swissmedic standards#

  • EU MDR Rule 8 / Rule 18 Compliance: Strict conformity assessment for implantable medical devices incorporating tissues or cells of human/animal origin.
  • European Bioprinting Hubs: Advanced collaborative research centers across Switzerland (ETH Zürich), Germany (Fraunhofer), and the Netherlands.
  • CE Marking Clinical Data Requirements: Comprehensive clinical evaluation reports verifying long-term tissue remodeling and integration safety.

China

NMPA Class III medical device approvals, national 3D printing centers#

  • NMPA Priority Review for Innovative Devices: Fast-track clinical review channels for 海洋鱼皮/鱼鳞生物酶解制备低聚肽与高凝胶鱼明胶成套加工技术 under Class III implantable medical device pathways.
  • National Biomanufacturing Centers: State key laboratories in Tsinghua, Zhejiang University, and Shanghai Jiao Tong accelerating clinical translation.
  • Regional Medical Device Industrial Parks: High-density clusters in Changzhou, Suzhou, and Shenzhen supplying medical-grade biodegradable polymers.

6 · Money: tenders & grants

7 · Tech stack & innovations

  1. Functional Bioink Formulation in Marine Fish-Skin Collagen Peptides and Fish Gelatin Bioprocessing:
    • Recombinant humanized collagen or modified gelatin matrices with defined methacrylation degrees.
    • Non-toxic visible-light photoinitiators (LAP) providing rapid crosslinking under low-intensity 405 nm irradiation.
  2. High-Precision Multi-Head Biofabrication:
    • Pneumatic extrusion printheads coupled with temperature-controlled peltier nozzles.
    • Laser-assisted or digital light processing (DLP) projections achieving sub-25 um feature resolution.
  3. Dynamic Biomimetic Tissue Bioreactors:
    • Continuous multichannel peristaltic perfusion circuits delivering oxygenated nutrient flow directly through lumen architectures.
    • Programmable mechanical actuators delivering cyclical uniaxial or radial stretch to condition structural cells.

Sources 2 · 2 independent · 0 producer sites

Independent sources 2

  1. www.ncbi.nlm.nih.gov research checked 2026-11-15
  2. doi.org research checked 2026-11-15